Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis disease-modifying therapy prescribing patterns in ontario.
Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders.
T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
New Drug Review 2010: Ustekinumab (Stelara, Centocor Ortho Biotech)
Oral Agent Outcomes
Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.
Astrocytes Underlie Neuroinflammatory Memory Impairment.
Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia.
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
Clinically isolated syndromes and the relationship to multiple sclerosis.
Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis.
Frequent but nonspecific venous narrowing in paediatric multiple sclerosis.
Time to see the light.
Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability.
Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter Lesions.
Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.
Extension Trial Data Shows Cladribine Benefits Persist in RRMS Patients
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
Seeing optic neuritis through myopic eyes.
Biomarkers in multiple sclerosis.
Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up.
Client-centred therapy in multiple sclerosis: More intensive diagnostic evaluation and less intensive treatment.
Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress.
Pages
« first
‹ previous
…
131
132
133
134
135
136
137
138
139
…
next ›
last »